Generic substitution in the treatment of epilepsy: Patient attitudes and perceptions

Epilepsy and Behavior

Volumn 26, Issue 1, 2013, Pages 64-66

  Ngo, Suong N T ^a   Stupans, Ieva ^b   McKinnon, Ross A ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF NEW ENGLAND   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

Antiepileptic drugs; Brand substitution; Patient's perceptions; Seizure

Indexed keywords

ANTICONVULSIVE AGENT; GENERIC DRUG;

ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SUBSTITUTION; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HEALTH CARE SURVEY; HUMAN; INFORMED CONSENT; MALE; PATIENT ATTITUDE; PERCEPTION; PILOT STUDY; POSTAL MAIL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; ATTITUDE TO HEALTH; AUSTRALIA; DRUG SUBSTITUTION; EPILEPSY; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PERCEPTION; THERAPEUTIC EQUIVALENCY; YOUNG ADULT;

EID: 84875238456     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.10.032     Document Type: Article

References (13)

1. Kumet R., Gelenberg A.J. The effectiveness of generic agents in psychopharmacologic treatment. Essential Psychopharmacol 2005, 6:4-11.
2. Borgheini G. The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs. Clin Ther 2003, 25:1578-1592.
3. Mofsen R., Balter J. Case reports of the re-emergency of psychotic symptoms after conversion from brand-name clozapine to a generic formulation. Clin Ther 2001, 23:1720-1731.
4. Guberman A., Corman C. Generic substitution for brand name antiepileptic drugs: a survey. Can J Neurol Sci 2000, 27:37-43.
5. Nuwer M.R., Browne T.R., Dodson W.E., et al. Generic substitutions for antiepileptic drugs. Neurology 1990, 40:1647-1651.
6. FDA Office of Generic Drugs [August, 2012]. http://www.fda.gov/cder/ogd/.
7. Ngo S.N.T. When do differences in dissolution profiles predict clinical problems?. J Clin Pharm Ther 2007, 32:111-112.
8. Reiffel J.A. Issues in the use of generic antiarrhythmic drugs. Curr Opin Cardiol 2001, 16:23-29.
9. Kumet R., Gelenberg A.J. The effectiveness of generic agents in psychopharmacologic treatment. Essent Pharmacol 2005, 6:4-11.
10. Ngo S.N.T., Ibrahim R., McLachlan A.J., McKinnon R.A. Patients' perceptions of generic medications. Proc Aust Soc Clin Exp Pharmacol Toxicol 2010, 44:166.
11. Berg M.J., Gross R.A., Haskins L.S., Zingaro W.M., Tomaszewski K.J. Generic substitution in the treatment of epilepsy: patient and physician perceptions. Epilepsy Behav 2008, 13:693-699.
12. Haskins L.S., Tomaszewski K.J., Crawford P. Patient and physician reactions to generic antiepileptic substitution in the treatment of epilepsy. Epilepsy Behav 2005, 7:98-105.
13. Wilner A.N. Therapeutic equivalency of generic antiepileptic drugs: results of a survey. Epilepsy Behav 2004, 5:995-998.